{"cursor":"28972","size":15,"audio":[],"currentlang":"en","article":"{{Drugbox\n | Verifiedfields = changed verifiedrevid = 470612477 image = HerceptinFab.jpg\n | width = 300\n\n\n | type = mab mab_type = mab source = zu/o target = HER2/neu\n\n\n | tradename = Herclon, Herceptin Drugs.com = pregnancy_US = D\n | pregnancy_category = X legal_status = routes_of_administration = Intravenous\n\n\n | bioavailability = protein_bound = metabolism = Unknown, possibly\n | reticuloendothelial system. elimination_half-life = 2-12 days\n\n\n| ChemSpiderID_Ref = ChemSpiderID = NA CAS_number_Ref = CAS_number = 180288-69-1\n| ATC_prefix = L01 ATC_suffix = XC03 ATC_supplemental = PubChem = DrugBank_Ref =\n| DrugBank = DB00072 UNII_Ref = UNII = P188ANX8CK KEGG_Ref = KEGG = D03257\n| ChEMBL_Ref = ChEMBL = 1201585\n\n\n | C=6470 | H=10012 | N=1726 | O=2013 | S=42 molecular_weight = 145531.5 g/mol\n}} \n\n'Trastuzumab' (INN; trade names 'Herclon', 'Herceptin') is a monoclonal antibody\nthat interferes with the HER2/neu receptor. Its main use is to treat certain\nbreast cancers.\n\nThe HER receptors are proteins that are embedded in the cell membrane and\ncommunicate molecular signals from outside the cell (molecules called EGFs) to\ninside the cell, and turn genes on and off. The HER proteins stimulate cell\nproliferation. In some cancers, notably certain types of breast cancer, HER2 is\nover-expressed, and causes cancer cells to reproduce uncontrollably. [http://content.nejm.org/cgi/content/full/357/1/39 Jul 5;357(1):39-\n51. Review /article]\n\nThe original studies of trastuzumab showed that it improved overall survival in\nlate-stage (metastatic) breast cancer from 20.3 to 25.1 months. In early stage breast cancer, it reduces the risk of cancer\nreturning after surgery by an absolute risk of 9.5%, and the risk of death by an\nabsolute risk of 3% however increases serious heart problems by an absolute risk\nof 2.1% which may resolve if treatment is stopped.\nTrastuzumab is controversial partly because of its cost, as much as $54,000 per\nyear, and while certain private insurance companies in the\nU.S. and government health care systems in Canada, UK and elsewhere have refused\nto pay for trastuzumab for certain patients, some companies have since accepted\ntrastuzumab treatment as a covered preventative treatment.\n\nTrastuzumab is also being studied for the treatment of other cancers. [http-\n://www.informapharmascience.com/doi/abs/10.1517/13543780902969455 Vecchione L.\nNovel investigational drugs for gastric cancer.] Expert Opin Investig Drugs.\n2009 May 26. [Epub ahead of publication]. Review /article. It has been\nused with some success in women with uterine papillary serous carcinomas that\noverexpress HER2/neu.\n","linknr":659,"url":"Herceptin","recorded":1376415747,"links":["/w/index.php?title=Trastuzumab&action=edit","/w/index.php?title=Trastuzumab&action=edit","//bits.wikimedia.org/favicon/wikipedia.ico","/w/opensearch_desc.php","//en.wikipedia.org/w/api.php?action=rsd","//creativecommons.org/licenses/by-sa/3.0/","/w/index.php?title=Special:RecentChanges&feed=atom","http://en.wikipedia.org/wiki/Trastuzumab","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=ext.gadget.DRN-wizard%2CReferenceTooltips%2Ccharinsert%2Cteahouse%7Cext.rtlcite%2Cwikihiero%7Cext.uls.nojs%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmw.PopUpMediaTransform%7Cskins.vector&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=ext.visualEditor.viewPageTarget.noscript&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=startup&only=scripts&skin=vector&*","//bits.wikimedia.org/geoiplookup","//meta.wikimedia.org","/w/index.php?title=Herceptin&redirect=no","#mw-navigation","#p-search","/wiki/Nomenclature_of_monoclonal_antibodies","/wiki/File:HerceptinFab.jpg","//upload.wikimedia.org/wikipedia/commons/thumb/0/0a/HerceptinFab.jpg/300px-HerceptinFab.jpg","/wiki/Monoclonal_antibody#Applications","/wiki/File:Engineered_monoclonal_antibodies.svg","/wiki/Monoclonal_antibody#Production","/wiki/Humanized","/wiki/Mouse","/wiki/Antigen","/wiki/HER2/neu","/wiki/Trade_name","/wiki/American_Society_of_Health-System_Pharmacists","/wiki/Drugs.com","http://www.drugs.com/monograph/trastuzumab.html","/wiki/Pregnancy_category","/wiki/United_States","/wiki/Regulation_of_therapeutic_goods","/wiki/Route_of_administration","/wiki/Drug_metabolism","/wiki/Biological_half-life","/wiki/CAS_registry_number","http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?term=180288-69-1&rn=1","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","/wiki/Anatomical_Therapeutic_Chemical_Classification_System","/wiki/ATC_code_L01","http://www.whocc.no/atc_ddd_index/?code=L01XC03","/wiki/DrugBank","http://www.drugbank.ca/drugs/DB00072","/wiki/Unique_Ingredient_Identifier","http://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=P188ANX8CK","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","/wiki/KEGG","http://www.kegg.jp/entry/D03257","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","/wiki/ChEMBL","https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL1201585","//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png","/wiki/Chemical_formula","/wiki/Carbon","/wiki/Hydrogen","/wiki/Nitrogen","/wiki/Oxygen","/wiki/Sulfur","/wiki/Molecular_mass","//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/14px-X_mark.svg.png","/wiki/Wikipedia:WikiProject_Chemicals/Chembox_validation","//en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=470612477&page2=Trastuzumab","/wiki/International_Nonproprietary_Name","/wiki/Monoclonal_antibody","/wiki/HER2/neu","/wiki/Receptor_(biochemistry)","/wiki/Epidermal_growth_factor","#cite_note-Hudis_2007-1","#cite_note-Hudis_2007-1","#cite_note-Cochrane2012-2","#cite_note-3","#cite_note-4","#cite_note-5","#cite_note-6","/wiki/Uterine_papillary_serous_carcinoma","#cite_note-7","#Medical_use","#Adverse_effects","#Mechanism_of_action","#Predicting_response_to_therapy","#Optimal_duration_of_adjuvant_trastuzumab","#History","#Costs","#See_also","#References","#Further_reading","#External_links","/w/index.php?title=Trastuzumab&action=edit&section=1","/w/index.php?title=Trastuzumab&veaction=edit&section=1","#cite_note-Hudis_2007-1","#cite_note-Cochrane2012-2","#cite_note-TanSwain-8","#cite_note-NahtaEsteva-9","#cite_note-YuHung-10","#cite_note-Kute-11","/w/index.php?title=Trastuzumab&action=edit&section=2","/w/index.php?title=Trastuzumab&veaction=edit&section=2","#cite_note-12","/wiki/MUGA_scan","/wiki/Echocardiography","#cite_note-13","/wiki/Cardiomyopathy","/wiki/Anthracycline","/w/index.php?title=Trastuzumab&action=edit&section=3","/w/index.php?title=Trastuzumab&veaction=edit&section=3","/wiki/Breast_cancer","/wiki/Epidermal_growth_factor","#cite_note-Bange-14","#cite_note-cancer-15","#cite_note-cancer-15","#cite_note-Feldman-16","#cite_note-17","/wiki/Mitogens","/wiki/Protein_dimer","/wiki/PI3K","/wiki/AKT","/wiki/Mitogen-activated_protein_kinase","/wiki/Angiogenesis","#cite_note-Menard-18","/wiki/Mitosis","/wiki/Cyclin-dependent_kinases","#cite_note-Kute-11","#cite_note-19","/wiki/Cell_cycle","/wiki/Downregulation","#cite_note-Kute-11","/wiki/Angiogenesis","#cite_note-Albenall-20","/wiki/Antibody-dependent_cell-mediated_cytotoxicity","#cite_note-21","/w/index.php?title=Trastuzumab&action=edit&section=4","/w/index.php?title=Trastuzumab&veaction=edit&section=4","/wiki/Clinical_laboratory","/wiki/Immunohistochemistry","/wiki/In_situ_hybridisation","/wiki/Virtual_Karyotype","/wiki/PCR","#cite_note-Jennings-22","#cite_note-23","/wiki/Ventana_Medical_Systems","#cite_note-ventanamed1-24","/wiki/Fluorescent_in_situ_hybridization","#cite_note-25","/wiki/Ventana_Medical_Systems","#cite_note-ventanamed1-24","#cite_note-26","/wiki/Automated_Tissue_Image_Systems","/w/index.php?title=Trastuzumab&action=edit&section=5","/w/index.php?title=Trastuzumab&veaction=edit&section=5","#cite_note-Romond-27","#cite_note-Piccart-28","#cite_note-29","#cite_note-Metcalfe-30","#cite_note-31","#cite_note-32","/w/index.php?title=Trastuzumab&action=edit&section=6","/w/index.php?title=Trastuzumab&veaction=edit&section=6","/wiki/Genentech","/wiki/UCLA","/wiki/Axel_Ullrich","/wiki/H._Michael_Shepard","/wiki/UCLA","/wiki/Jonsson_Comprehensive_Cancer_Center","#cite_note-33","/wiki/Dennis_Slamon","/wiki/Living_Proof_(film)","/w/index.php?title=Trastuzumab&action=edit&section=7","/w/index.php?title=Trastuzumab&veaction=edit&section=7","#cite_note-34","#cite_note-35","#cite_note-36","#cite_note-37","#cite_note-38","#cite_note-39","/wiki/Pharmaceutical_Benefits_Scheme","#cite_note-40","/wiki/Emcure","#cite_note-41","/wiki/Wikipedia:Citation_needed","/w/index.php?title=Trastuzumab&action=edit&section=8","/w/index.php?title=Trastuzumab&veaction=edit&section=8","/wiki/Personalized_medicine","/wiki/Trastuzumab_emtansine","/w/index.php?title=Trastuzumab&action=edit&section=9","/w/index.php?title=Trastuzumab&veaction=edit&section=9","#cite_ref-Hudis_2007_1-0","#cite_ref-Hudis_2007_1-1","#cite_ref-Hudis_2007_1-2","/wiki/Digital_object_identifier","http://dx.doi.org/10.1056%2FNEJMra043186","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/17611206","http://content.nejm.org/cgi/content/full/357/1/39","#cite_ref-Cochrane2012_2-0","#cite_ref-Cochrane2012_2-1","/wiki/Digital_object_identifier","http://dx.doi.org/10.1002%2F14651858.CD006243.pub2","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/22513938","#cite_ref-3","http://online.wsj.com/article/SB10000872396390444592404578030092105035814.html","#cite_ref-4","http://www.nytimes.com/2012/10/02/business/current-length-of-herceptin-treatment-is-supported-by-studies.html?_r=0","#cite_ref-5","http://www.thisismoney.co.uk/insurance/health/article.html?in_article_id=409897&in_page_id=39","#cite_ref-6","http://www.informapharmascience.com/doi/abs/10.1517/13543780902969455","#cite_ref-7","/wiki/Digital_object_identifier","http://dx.doi.org/10.1016%2Fj.ijgo.2008.04.008","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/18555254","#cite_ref-TanSwain_8-0","/wiki/Digital_object_identifier","http://dx.doi.org/10.1053%2Fj.seminoncol.2003.08.008","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/14613027","#cite_ref-NahtaEsteva_9-0","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/14613984","#cite_ref-YuHung_10-0","/wiki/Digital_object_identifier","http://dx.doi.org/10.1038%2Fsj.onc.1203972","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/11156524","#cite_ref-Kute_11-0","#cite_ref-Kute_11-1","#cite_ref-Kute_11-2","/wiki/Digital_object_identifier","http://dx.doi.org/10.1002%2Fcyto.a.10095","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/14750129","#cite_ref-12","/wiki/Digital_object_identifier","http://dx.doi.org/10.1200%2FJCO.20.5.1215","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/11870163","#cite_ref-13","#cite_ref-Bange_14-0","/wiki/Digital_object_identifier","http://dx.doi.org/10.1038%2F87872","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/11329054","#cite_ref-cancer_15-0","#cite_ref-cancer_15-1","http://www.cancer.gov/cancertopics/understandingcancer/targetedtherapies/breastcancer_htmlcourse/page3","#cite_ref-Feldman_16-0","/wiki/Digital_object_identifier","http://dx.doi.org/10.1038%2Fsj.clpt.6100160","/wiki/Help:CS1_errors#accessdate_missing_url","#cite_ref-17","http://www.medscape.org/viewarticle/557474","#cite_ref-Menard_18-0","/wiki/Digital_object_identifier","http://dx.doi.org/10.1038%2Fsj.onc.1206779","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/14528282","#cite_ref-19","http://www.nature.com/nature/journal/v421/n6924/full/nature01392.html","#cite_ref-Albenall_20-0","/wiki/Digital_object_identifier","http://dx.doi.org/10.1007%2F978-1-4615-0081-0_21","/wiki/International_Standard_Book_Number","/wiki/Special:BookSources/978-0-306-47762-1","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/12908564","#cite_ref-21","/wiki/Digital_object_identifier","http://dx.doi.org/10.1038%2F74704","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/10742152","#cite_ref-Jennings_22-0","/wiki/Digital_object_identifier","http://dx.doi.org/10.1136%2Fmp.50.5.254","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/9497915","#cite_ref-23","http://www.dakousa.com/index/prod_search/prod_baseproducts.htm?productareaid=1&productgroupid=3&productsubgroupid=1003000","#cite_ref-ventanamed1_24-0","#cite_ref-ventanamed1_24-1","http://www.ventanamed.com/","#cite_ref-25","http://www.bioportfolio.com/news/article/711287/Ventana-Medical-Systems-Inc-Receives-Fda-Approval-For-The-First-Fully-Automated.html","#cite_ref-26","http://www.asco.org/ascov2/Meetings/Abstracts?&vmview=abst_detail_view&confID=70&abstractID=40271","#cite_ref-Romond_27-0","/wiki/New_England_Journal_of_Medicine","/wiki/Digital_object_identifier","http://dx.doi.org/10.1056%2FNEJMoa052122","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/16236738","#cite_ref-Piccart_28-0","/wiki/New_England_Journal_of_Medicine","/wiki/Digital_object_identifier","http://dx.doi.org/10.1056%2FNEJMoa052306","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/16236737","#cite_ref-29","/wiki/Digital_object_identifier","http://dx.doi.org/10.1056%2FNEJMoa053028","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/16495393","#cite_ref-Metcalfe_30-0","/wiki/N_Z_Med_J","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/17589560","#cite_ref-31","http://www.roche.com/investors/ir_update/inv-update-2012-10-01.htm","#cite_ref-32","http://www.esmo.org/events/vienna-2012-congress/congress-news/view.html?tx_ttnews%5Btt_news%5D=1673","#cite_ref-33","http://www.cancer.ucla.edu/","#cite_ref-34","/wiki/Digital_object_identifier","http://dx.doi.org/10.1353%2Fhcr.2006.0040","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/16776017","#cite_ref-35","http://www.health.gov.au/internet/main/publishing.nsf/Content/herceptin-govtdecision.htm","#cite_ref-36","http://www.nzherald.co.nz/search/story.cfm?storyid=00001939-D9A0-1532-910183027AF1010F","#cite_ref-37","http://news.bbc.co.uk/2/hi/health/4684852.stm","#cite_ref-38","http://www.nice.org.uk/page.aspx?o=328396","#cite_ref-39","http://www.cbc.ca/canada/toronto/story/2005/07/22/to-drugtherapies20050722.html","#cite_ref-40","http://www.health.gov.au/internet/main/publishing.nsf/Content/herceptin-govtdecision.htm","#cite_ref-41","http://articles.economictimes.indiatimes.com/2012-03-02/news/31117087_1_emcure-pharmaceuticals-anti-hiv-drugs-emcure-signs-deal","/w/index.php?title=Trastuzumab&action=edit&section=10","/w/index.php?title=Trastuzumab&veaction=edit&section=10","/wiki/Special:BookSources/067945702X","http://www.guardian.co.uk/science/story/0,,1742168,00.html","http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2722050","/wiki/PubMed_Central","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2722050","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/19672422","http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2722050/?tool=pubmed","/w/index.php?title=Trastuzumab&action=edit&section=11","/w/index.php?title=Trastuzumab&veaction=edit&section=11","http://www.herceptin.com/herceptin/patient/index.jsp","http://www.cancer.gov/cancertopics/druginfo/trastuzumab","http://gentaur-worldwide.com/index.php?option=com_k2&view=item&id=78:trastuzumab-increases-the-relative-risk-of-brain-metastases&Itemid=530","//upload.wikimedia.org/wikipedia/commons/thumb/f/f8/Wiktionary-logo-en.svg/37px-Wiktionary-logo-en.svg.png","//en.wiktionary.org/wiki/Special:Search/trastuzumab","/wiki/Template:Extracellular_chemotherapeutic_agents","/wiki/Template_talk:Extracellular_chemotherapeutic_agents","//en.wikipedia.org/w/index.php?title=Template:Extracellular_chemotherapeutic_agents&action=edit","/wiki/Targeted_therapy","/wiki/Chemotherapy_(oncology)","/wiki/Antineoplastic","/wiki/ATC_code_L01","/wiki/Cancer_immunotherapy","/wiki/Monoclonal_antibody_therapy","/wiki/Receptor_tyrosine_kinase","/wiki/ErbB","/wiki/Epidermal_growth_factor_receptor","/wiki/Cetuximab","/wiki/Panitumumab","/wiki/HER2/neu","/wiki/Trastuzumab_emtansine","/wiki/EpCAM","/wiki/Catumaxomab","/wiki/Edrecolomab","/wiki/Vascular_endothelial_growth_factor_A","/wiki/Bevacizumab","/wiki/Leukemia","/wiki/Lymphoma","/wiki/Lymphatic_system","/wiki/CD20","/wiki/Ibritumomab_tiuxetan","/wiki/Ofatumumab","/wiki/Rituximab","/wiki/Tositumomab","/wiki/CD30","/wiki/Brentuximab_vedotin","/wiki/CD52","/wiki/Alemtuzumab","/wiki/Myeloid","/wiki/CD33","/wiki/Gemtuzumab_ozogamicin","/wiki/Tyrosine-kinase_inhibitor","/wiki/Receptor_tyrosine_kinase","/wiki/ErbB","/wiki/Epidermal_growth_factor_receptor","/wiki/Erlotinib","/wiki/Gefitinib","/wiki/Vandetanib","/wiki/HER2/neu","/wiki/Afatinib","/wiki/Lapatinib","/wiki/Neratinib","/wiki/RTK_class_III","/wiki/CD117","/wiki/Platelet-derived_growth_factor_receptor","/wiki/Axitinib","/wiki/Masitinib","/wiki/Pazopanib","/wiki/Sunitinib","/wiki/Sorafenib","/wiki/Toceranib","/wiki/CD135","/wiki/Lestaurtinib","/wiki/VEGF_receptors","/wiki/Axitinib","/wiki/Cediranib","/wiki/Pazopanib","/wiki/Regorafenib","/wiki/Semaxanib","/wiki/Sorafenib","/wiki/Sunitinib","/wiki/Toceranib","/wiki/Vandetanib","/wiki/Non-receptor_tyrosine_kinase","/wiki/Bcr-abl_fusion_protein","/wiki/Imatinib","/wiki/Dasatinib","/wiki/Nilotinib","/wiki/Ponatinib","/wiki/Src_(gene)","/wiki/Bosutinib","/wiki/Janus_kinase","/wiki/Lestaurtinib","/wiki/Ruxolitinib","/wiki/EML4","/wiki/Anaplastic_lymphoma_kinase","/wiki/Crizotinib","/wiki/Vandetanib","/wiki/Cabozantinib","/wiki/Fusion_protein","/wiki/Vascular_endothelial_growth_factor","/wiki/Aflibercept","/wiki/Proapoptotic","/wiki/ANXA2","/wiki/Prohibitin","/wiki/Adipotide","/wiki/Exotoxin","/wiki/Interleukin_2","/wiki/Denileukin_diftitox","/wiki/MTOR_inhibitor","/wiki/Everolimus","/wiki/Temsirolimus","/wiki/Template:Medicine_navs","/wiki/Neoplasm","/wiki/Template:Tumor_suppressor_genes_and_oncogenes","/wiki/Template:Tumor_markers","/wiki/Template:Tumors","/wiki/Template:Eponymous_medical_signs_for_oncology","/wiki/Template:Paraneoplastic_syndromes","/wiki/ATC_code_L","/wiki/Template:Intracellular_chemotherapeutic_agents","/wiki/Template:Extracellular_chemotherapeutic_agents","/wiki/Template:Detoxifying_agents_for_antineoplastic_treatment","/wiki/Template:Monoclonals_for_tumors","/wiki/Template_talk:Monoclonals_for_tumors","//en.wikipedia.org/w/index.php?title=Template:Monoclonals_for_tumors&action=edit","/wiki/Monoclonal_antibodies","/wiki/Tumor","/wiki/Adecatumumab","/wiki/Cixutumumab","/wiki/Conatumumab","/wiki/Daratumumab","/wiki/Drozitumab","/wiki/Duligotumab","/wiki/Dusigitumab","/wiki/Figitumumab","/wiki/Ganitumab","/wiki/Glembatumumab_vedotin","/wiki/Intetumumab","/wiki/Iratumumab","/wiki/Lexatumumab","/wiki/Lucatumumab","/wiki/Mapatumumab","/wiki/Narnatumab","/wiki/Necitumumab","/wiki/Ofatumumab","/wiki/Olaratumab","/wiki/Panitumumab","/wiki/Patritumab","/wiki/Pritumumab","/wiki/Radretumab","/wiki/Rilotumumab","/wiki/Robatumumab","/wiki/Teprotumumab","/wiki/Tovetumab","/wiki/Vantictumab","/wiki/Technetium_(99mTc)_votumumab","/wiki/Zalutumumab","/wiki/Melanoma","/wiki/Flanvotumab","/wiki/Indium_(111In)_altumomab_pentetate","/wiki/Anatumomab_mafenatox","/wiki/Technetium_(99mTc)_arcitumomab","/wiki/Bectumomab","/wiki/Blinatumomab","/wiki/Iodine_(125I)_CC49","/wiki/Detumomab","/wiki/Ibritumomab_tiuxetan","/wiki/Minretumomab","/wiki/Mitumomab","/wiki/Moxetumomab_pasudotox","/wiki/Naptumomab_estafenatox","/wiki/Technetium_(99mTc)_nofetumomab_merpentan","/wiki/Pemtumomab","/wiki/Technetium_(99mTc)_pintumomab","/wiki/Racotumomab","/wiki/Indium_(111In)_satumomab_pendetide","/wiki/Solitomab","/wiki/Taplitumomab_paptox","/wiki/Tenatumomab","/wiki/Tositumomab","/wiki/3F8","/wiki/Ovarian_tumor","/wiki/Abagovomab","/wiki/Indium_(111In)_igovomab","/wiki/Oregovomab","/wiki/Indium_(111In)_capromab_pendetide","/wiki/Edrecolomab","/wiki/Nacolomab_tafenatox","/wiki/Chimeric_antibody","/wiki/Amatuximab","/wiki/Bavituximab","/wiki/Brentuximab_vedotin","/wiki/Cetuximab","/wiki/Ensituximab","/wiki/Futuximab","/wiki/Girentuximab","/wiki/Indatuximab_ravtansine","/wiki/Margetuximab","/wiki/Rituximab","/wiki/Siltuximab","/wiki/Ublituximab","/wiki/Melanoma","/wiki/Ecromeximab","/wiki/Humanized_antibody","/wiki/Afutuzumab","/wiki/Alemtuzumab","/wiki/Bevacizumab","/wiki/Bivatuzumab_mertansine","/wiki/Cantuzumab_mertansine","/wiki/Cantuzumab_ravtansine","/wiki/Citatuzumab_bogatox","/wiki/Yttrium_(90Y)_clivatuzumab_tetraxetan","/wiki/Dacetuzumab","/wiki/Dalotuzumab","/wiki/Elotuzumab","/wiki/Etaracizumab","/wiki/Farletuzumab","/wiki/Ficlatuzumab","/wiki/Gemtuzumab_ozogamicin","/wiki/Imgatuzumab","/wiki/Inotuzumab_ozogamicin","/wiki/Labetuzumab","/wiki/Lintuzumab","/wiki/Lorvotuzumab_mertansine","/wiki/Matuzumab","/wiki/Milatuzumab","/wiki/Nimotuzumab","/wiki/Ocaratuzumab","/wiki/Onartuzumab","/wiki/Oportuzumab_monatox","/wiki/Parsatuzumab","/wiki/Pertuzumab","/wiki/Sibrotuzumab","/wiki/Simtuzumab","/wiki/Yttrium_(90Y)_tacatuzumab_tetraxetan","/wiki/Tigatuzumab","/wiki/Tucotuzumab_celmoleukin","/wiki/Veltuzumab","/wiki/Vorsetuzumab_mafodotin","/wiki/Trifunctional_antibody","/wiki/Catumaxomab","/wiki/Ertumaxomab","/wiki/Ontuxizumab","/wiki/List_of_World_Health_Organization_Essential_Medicines","/wiki/List_of_withdrawn_drugs","/wiki/Clinical_trial","/wiki/Clinical_trial#Phase_III","/wiki/Clinical_trial#Phase_II","//en.wikipedia.org/w/index.php?title=Special:CentralAutoLogin/start&type=1x1&from=enwiki","http://en.wikipedia.org/w/index.php?title=Trastuzumab&oldid=563387256","/wiki/Help:Category","/wiki/Category:Monoclonal_antibodies_for_tumors","/wiki/Category:Pages_using_citations_with_accessdate_and_no_URL","/wiki/Category:Chemical_compounds_which_do_not_have_a_ChemSpiderID","/wiki/Category:Articles_with_changed_EBI_identifier","/wiki/Category:Drugboxes_which_contain_changes_to_verified_fields","/wiki/Category:All_articles_with_unsourced_statements","/wiki/Category:Articles_with_unsourced_statements_from_June_2013","/wiki/Category:Requests_for_audio_pronunciation_(English)","/w/index.php?title=Special:UserLogin&returnto=Trastuzumab&type=signup","/w/index.php?title=Special:UserLogin&returnto=Trastuzumab","/wiki/Trastuzumab","/wiki/Talk:Trastuzumab","#","/wiki/Trastuzumab","/w/index.php?title=Trastuzumab&action=edit","/w/index.php?title=Trastuzumab&veaction=edit","/w/index.php?title=Trastuzumab&action=history","#","/w/index.php","//bits.wikimedia.org/static-1.22wmf12/skins/vector/images/search-ltr.png?303-4","/wiki/Main_Page","/wiki/Main_Page","/wiki/Portal:Contents","/wiki/Portal:Featured_content","/wiki/Portal:Current_events","/wiki/Special:Random","https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&utm_medium=sidebar&utm_campaign=C13_en.wikipedia.org&uselang=en","/wiki/Help:Contents","/wiki/Wikipedia:About","/wiki/Wikipedia:Community_portal","/wiki/Special:RecentChanges","//en.wikipedia.org/wiki/Wikipedia:Contact_us","/wiki/Special:WhatLinksHere/Trastuzumab","/wiki/Special:RecentChangesLinked/Trastuzumab","/wiki/Wikipedia:File_Upload_Wizard","/wiki/Special:SpecialPages","/w/index.php?title=Trastuzumab&oldid=563387256","/w/index.php?title=Trastuzumab&action=info","//www.wikidata.org/wiki/Q412616","/w/index.php?title=Special:Cite&page=Trastuzumab&id=563387256","/w/index.php?title=Special:Book&bookcmd=book_creator&referer=Trastuzumab","/w/index.php?title=Special:Book&bookcmd=render_article&arttitle=Trastuzumab&oldid=563387256&writer=rl","/w/index.php?title=Trastuzumab&printable=yes","//ar.wikipedia.org/wiki/%D8%AA%D8%B1%D8%A7%D8%B2%D8%AA%D9%88%D8%B2%D9%88%D9%85%D8%A7%D8%A8","//da.wikipedia.org/wiki/Trastuzumab","//de.wikipedia.org/wiki/Trastuzumab","//es.wikipedia.org/wiki/Trastuzumab","//fa.wikipedia.org/wiki/%D8%AA%D8%B1%D8%A7%D8%B2%D8%AA%D9%88%D8%B2%D9%88%D9%85%D8%A7%D8%A8","//fr.wikipedia.org/wiki/Trastuzumab","//it.wikipedia.org/wiki/Trastuzumab","//he.wikipedia.org/wiki/%D7%94%D7%A8%D7%A6%D7%A4%D7%98%D7%99%D7%9F","//ja.wikipedia.org/wiki/%E3%83%88%E3%83%A9%E3%82%B9%E3%83%84%E3%82%BA%E3%83%9E%E3%83%96","//pl.wikipedia.org/wiki/Trastuzumab","//pt.wikipedia.org/wiki/Trastuzumabe","//sl.wikipedia.org/wiki/Trastuzumab","//zh.wikipedia.org/wiki/%E6%9B%B2%E5%A6%A5%E7%8F%A0%E5%8D%95%E6%8A%97","#","//www.wikidata.org/wiki/Q412616#sitelinks-wikipedia","//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License","//creativecommons.org/licenses/by-sa/3.0/","//wikimediafoundation.org/wiki/Terms_of_Use","//wikimediafoundation.org/wiki/Privacy_policy","//www.wikimediafoundation.org/","//wikimediafoundation.org/wiki/Privacy_policy","/wiki/Wikipedia:About","/wiki/Wikipedia:General_disclaimer","//en.wikipedia.org/wiki/Wikipedia:Contact_us","//en.m.wikipedia.org/wiki/Trastuzumab","//wikimediafoundation.org/","//bits.wikimedia.org/images/wikimedia-button.png","//www.mediawiki.org/","//bits.wikimedia.org/static-1.22wmf12/skins/common/images/poweredby_mediawiki_88x31.png","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=scripts&skin=vector&*"],"instances":["biochemistry"],"pdf":[],"categories":["Monoclonal antibodies for tumors","Requests for audio pronunciation (English)"],"headings":["Medical use","Adverse effects","Mechanism of action","Predicting response to therapy","Optimal duration of adjuvant trastuzumab","History","Costs","See also","References","Further reading","External links"],"image":["//upload.wikimedia.org/wikipedia/commons/thumb/0/0a/HerceptinFab.jpg/300px-HerceptinFab.jpg","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","//upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png","//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png","//upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/14px-X_mark.svg.png","//upload.wikimedia.org/wikipedia/commons/thumb/f/f8/Wiktionary-logo-en.svg/37px-Wiktionary-logo-en.svg.png","//en.wikipedia.org/w/index.php?title=Special:CentralAutoLogin/start&type=1x1&from=enwiki","//bits.wikimedia.org/static-1.22wmf12/skins/vector/images/search-ltr.png?303-4","//bits.wikimedia.org/images/wikimedia-button.png","//bits.wikimedia.org/static-1.22wmf12/skins/common/images/poweredby_mediawiki_88x31.png"],"tags":[["receptor","biochemistry"]],"members":["receptor"],"related":["HER2/neu","International_Nonproprietary_Name","Monoclonal_antibody","HER2/neu","Receptor_(biochemistry)","Epidermal_growth_factor","Uterine_papillary_serous_carcinoma","MUGA_scan","Echocardiography","Cardiomyopathy","Anthracycline","Breast_cancer","Epidermal_growth_factor","Mitogens","Protein_dimer","PI3K","AKT","Mitogen-activated_protein_kinase","Angiogenesis","Mitosis","Cyclin-dependent_kinases","Cell_cycle","Downregulation","Angiogenesis","Antibody-dependent_cell-mediated_cytotoxicity","Clinical_laboratory","Immunohistochemistry","In_situ_hybridisation","Virtual_Karyotype","PCR","Ventana_Medical_Systems","Fluorescent_in_situ_hybridization","Ventana_Medical_Systems","Automated_Tissue_Image_Systems","Genentech","UCLA","Axel_Ullrich","H._Michael_Shepard","UCLA","Jonsson_Comprehensive_Cancer_Center","Dennis_Slamon","Pharmaceutical_Benefits_Scheme","Emcure","Personalized_medicine","Trastuzumab_emtansine"]}